Securities code: 600789 securities abbreviation: Shandong Lukang Pharmaceutical Co.Ltd(600789) Announcement No.: 2022-008 Shandong Lukang Pharmaceutical Co.Ltd(600789)
Announcement on the acceptance of the application for public offering of allotment shares by the CSRC
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Shandong Lukang Pharmaceutical Co.Ltd(600789) (hereinafter referred to as the “company”) recently received the acceptance form of administrative license application of CSRC (acceptance No.: 220234) issued by China Securities Regulatory Commission (hereinafter referred to as the “CSRC”), and the CSRC examined the administrative license application materials submitted by the company according to law, Considering that the application materials are complete, it is decided to accept the application for administrative license.
The company’s share allotment still needs to be approved by the CSRC. According to the progress of the above matters, the company will timely perform the obligation of information disclosure in strict accordance with the provisions of relevant laws and regulations. Please pay attention to the investment risks.
It is hereby announced.
Shandong Lukang Pharmaceutical Co.Ltd(600789) board of directors February 9, 2022
